1. Home
  2. BWEN vs XLO Comparison

BWEN vs XLO Comparison

Compare BWEN & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Broadwind Inc.

BWEN

Broadwind Inc.

HOLD

Current Price

$3.58

Market Cap

49.1M

Sector

Industrials

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$0.64

Market Cap

41.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWEN
XLO
Founded
N/A
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.1M
41.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BWEN
XLO
Price
$3.58
$0.64
Analyst Decision
Strong Buy
Buy
Analyst Count
1
1
Target Price
$6.00
$2.00
AVG Volume (30 Days)
263.3K
305.9K
Earning Date
03-04-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
63.89
N/A
EPS
0.23
N/A
Revenue
$153,877,000.00
$31,804,000.00
Revenue This Year
$11.68
$626.78
Revenue Next Year
N/A
$79.08
P/E Ratio
$15.55
N/A
Revenue Growth
N/A
588.40
52 Week Low
$1.41
$0.62
52 Week High
$4.15
$1.70

Technical Indicators

Market Signals
Indicator
BWEN
XLO
Relative Strength Index (RSI) 56.30 39.17
Support Level $3.32 $0.63
Resistance Level $4.15 $0.74
Average True Range (ATR) 0.29 0.03
MACD 0.02 -0.00
Stochastic Oscillator 56.99 10.01

Price Performance

Historical Comparison
BWEN
XLO

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.

Share on Social Networks: